Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists

被引：44

作者：

Abel, Ulrich ^{[1
]}

Schlueter, Thomas ^{[1
]}

Schulz, Andreas ^{[1
]}

Hambruch, Eva ^{[1
]}

Steeneck, Christoph ^{[1
]}

Hornberger, Martin ^{[1
]}

Hoffmann, Thomas ^{[1
]}

Perovic-Ottstadt, Sanja ^{[1
]}

Kinzel, Olaf ^{[1
]}

Burnet, Michael ^{[2
]}

Deuschle, Ulrich ^{[1
]}

Kremoser, Claus ^{[1
]}

机构：

[1] Phenex Pharmaceut AG, D-69123 Heidelberg, Germany

[2] Synovo GmbH, D-72076 Tubingen, Germany

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 16期

关键词：

Farnesoid X receptor; FXR agonist; GW4064; db/db mice; Metabolic syndrome; FARNESOID-X-RECEPTOR; ORPHAN NUCLEAR RECEPTOR; BILE-ACIDS; IDENTIFICATION; HOMEOSTASIS; MICE;

D O I：

10.1016/j.bmcl.2010.06.084

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

To overcome the known liabilities of GW4064 a series of analogs were synthesized where the stilbene double bond is replaced by an oxymethylene or amino-methylene linker connecting a terminal benzoic acid with a substituted heteroaryl in the middle ring position. As a result we discovered compounds with increased potency in vitro that cause dose-dependent reduction of plasma triglycerides and cholesterol in db/db mice down to 2 x 1 mg/kg/day upon oral administration. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：4911 / 4917

页数：7

共 50 条

[41] TNFα-induced glucocorticoid resistance: Effect of steroidal and non-steroidal GR agonists, formoterol and inhibition of inflammatory signalling
Rider, Christopher
Shah, Suharsh
Miller-Larsson, Anna
Proud, David
Johnson, Malcolm
Giembycz, Mark
Newton, Robert
EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[42] The molecular modelling of a series of steroidal and non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase (17β-HSD)
Shahid, I.
Lota, R.
Owen, C. P.
Ahmed, S.
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S39 - S39
[43] Significant in-Vitro and in-Vivo inhibition of HBsAg and HBV pgRNA with ASC42, a novel non-steroidal FXR agonist
Wu, Jinzi
Li, Xiaodong
He, Handan
Zhou, Qiong
JOURNAL OF HEPATOLOGY, 2021, 75 : S703 - S704
[44] NON-STEROIDAL ANTI-INFLAMMATORY AGENTS .2. SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF NON-ACIDIC ARYLPYRROLE DERIVATIVES
MASSA, S
STEFANCICH, G
ARTICO, M
CORELLI, F
BAGLIONI, A
ANGELUCCI, L
FARMACO-EDIZIONE SCIENTIFICA, 1983, 38 (02): : 90 - 100
[45] Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists
Liu, Peng
Xu, Xing
Chen, Lili
Ma, Lei
Shen, Xu
Hu, Lihong
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (05) : 1596 - 1607
[46] ANTIESTROGENIC AND ANTI-TUMOR ACTIVITIES OF A SERIES OF NON-STEROIDAL ANTIESTROGENS
WAKELING, AE
VALCACCIA, B
JOURNAL OF ENDOCRINOLOGY, 1983, 99 (03) : 455 - 464
[47] ETODOLAC, A NOVEL NON-STEROIDAL ANTI-INFLAMMATORY AGENT
MULLANE, JF
ARNOLD, JD
ROLLY, G
VETTER, G
JOUBERT, L
JACOB, G
JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04): : A11 - A11
[48] Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
Kintscher, Ulrich
Bakris, George L.
Kolkhof, Peter
BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3220 - 3234
[49] An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis
Bennett, D. Jonathan
D Brown, Lindsay
Cooke, Andrew J.
Edwards, Andrew S.
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (12) : 1673 - 1699
[50] Synthesis of novel heterocyclic curcumin derivatives as non-steroidal anti-inflammatory drug candidates
Ahmed, M.
Woodroofe, M.
Bunning, R.
Rainsford, K.
Khan, M.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 87 - 87

← 1 2 3 4 5 →